Literature DB >> 18718756

7-[1H-Indol-2-yl]-2,3-dihydro-isoindol-1-ones as dual Aurora-A/VEGF-R2 kinase inhibitors: design, synthesis, and biological activity.

Terry V Hughes1, Stuart L Emanuel, Harold R O'Grady, Peter J Connolly, Catherine Rugg, Angel R Fuentes-Pesquera, Prabha Karnachi, Richard Alexander, Steven A Middleton.   

Abstract

A novel series of 7-[1H-indol-2-yl]-2,3-dihydro-isoindol-1-ones designed to be inhibitors of VEGF-R2 kinase was synthesized and found to potently inhibit VEGF-R2 and Aurora-A kinases. The structure-based design, synthesis, and initial SAR of the series are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18718756     DOI: 10.1016/j.bmcl.2008.07.090

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Identification of new novel scaffold for Aurora A inhibition by pharmacophore modeling and virtual screening.

Authors:  Sayalee R Chavan; Radha Charan Dash; M Sarwar Alam; Raj R Hirwani
Journal:  Mol Divers       Date:  2014-08-12       Impact factor: 2.943

2.  Novel Aurora/vascular endothelial growth factor receptor dual kinase inhibitor as treatment for hepatocellular carcinoma.

Authors:  Keisuke Nakao; Shinji Tanaka; Tomoya Miura; Kota Sato; Satoshi Matsumura; Arihiro Aihara; Yusuke Mitsunori; Daisuke Ban; Takanori Ochiai; Atsushi Kudo; Shigeki Arii; Minoru Tanabe
Journal:  Cancer Sci       Date:  2015-06-25       Impact factor: 6.716

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.